Novel analytical methods to interpret large sequencing data from small sample sizes

BACKGROUND: Targeted therapies have greatly improved cancer patient prognosis. For instance, chronic myeloid leukemia is now well treated with imatinib, a tyrosine kinase inhibitor. Around 80% of the patients reach complete remission. However, despite its great efficiency, some patients are resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Lichou, Florence, Orazio, Sébastien, Dulucq, Stéphanie, Etienne, Gabriel, Longy, Michel, Hubert, Christophe, Groppi, Alexis, Monnereau, Alain, Mahon, François-Xavier, Turcq, Béatrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717342/
https://www.ncbi.nlm.nih.gov/pubmed/31470908
http://dx.doi.org/10.1186/s40246-019-0235-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717342/
https://www.ncbi.nlm.nih.gov/pubmed/31470908
http://dx.doi.org/10.1186/s40246-019-0235-1

Ejemplares similares